Cargando…
A Pharmacovigilance Study of Drug-Induced Glaucoma Utilizing the Japanese Adverse Event Reporting System
PURPOSE: Clinically, glaucoma is a serious problem because it is asymptomatic until a relatively late stage in most cases, which can lead to delays in the diagnosis and treatment of the disease. The purpose of this study was to clarify the rank-order of the association of glaucoma with the causative...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693769/ https://www.ncbi.nlm.nih.gov/pubmed/38050555 http://dx.doi.org/10.2147/OPTH.S439255 |
_version_ | 1785153233936711680 |
---|---|
author | Kozaru, Mariko Iida, Tatsuya Hosohata, Keiko |
author_facet | Kozaru, Mariko Iida, Tatsuya Hosohata, Keiko |
author_sort | Kozaru, Mariko |
collection | PubMed |
description | PURPOSE: Clinically, glaucoma is a serious problem because it is asymptomatic until a relatively late stage in most cases, which can lead to delays in the diagnosis and treatment of the disease. The purpose of this study was to clarify the rank-order of the association of glaucoma with the causative drugs using a spontaneous reporting system database. METHODS: Data were extracted from the Japanese Adverse Drug Event Report database of the Pharmaceuticals and Medical Devices Agency (Japan). Based on reports of glaucoma caused by all drugs, we calculated the reporting odds ratio (ROR) and 95% confidence interval (CI) for glaucoma. RESULTS: Among 609 reports of adverse events corresponding to glaucoma (46%, women), the most frequently implicated drug were steroids (prednisolone, betamethasone sodium phosphate, triamcinolone acetonide, and fluorometholone), pregabalin, ranibizumab, crizotinib, tacrolimus hydrate, darbepoetin alfa, and foscarnet sodium hydrate. Among 207 reports involved in angle-closure glaucoma (86%, women), anticholinergic drug and antidepressants ranked high and showed signals. Signals were also detected in bromazepam (ROR, 69.7; 95% CI, 30.9–157.5), oral brotizolam (ROR, 16.6; 95% CI, 6.18–44.8), and oral milnacipran hydrochloride (ROR, 22.8; 95% CI, 8.46–61.4) for angle-closure glaucoma. CONCLUSION: A national pharmacovigilance database enabled us to identify the drugs that frequently induce glaucoma. The likelihood of the reporting of glaucoma varied among the drugs, which should be used carefully in clinical practice to avoid it. |
format | Online Article Text |
id | pubmed-10693769 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-106937692023-12-04 A Pharmacovigilance Study of Drug-Induced Glaucoma Utilizing the Japanese Adverse Event Reporting System Kozaru, Mariko Iida, Tatsuya Hosohata, Keiko Clin Ophthalmol Original Research PURPOSE: Clinically, glaucoma is a serious problem because it is asymptomatic until a relatively late stage in most cases, which can lead to delays in the diagnosis and treatment of the disease. The purpose of this study was to clarify the rank-order of the association of glaucoma with the causative drugs using a spontaneous reporting system database. METHODS: Data were extracted from the Japanese Adverse Drug Event Report database of the Pharmaceuticals and Medical Devices Agency (Japan). Based on reports of glaucoma caused by all drugs, we calculated the reporting odds ratio (ROR) and 95% confidence interval (CI) for glaucoma. RESULTS: Among 609 reports of adverse events corresponding to glaucoma (46%, women), the most frequently implicated drug were steroids (prednisolone, betamethasone sodium phosphate, triamcinolone acetonide, and fluorometholone), pregabalin, ranibizumab, crizotinib, tacrolimus hydrate, darbepoetin alfa, and foscarnet sodium hydrate. Among 207 reports involved in angle-closure glaucoma (86%, women), anticholinergic drug and antidepressants ranked high and showed signals. Signals were also detected in bromazepam (ROR, 69.7; 95% CI, 30.9–157.5), oral brotizolam (ROR, 16.6; 95% CI, 6.18–44.8), and oral milnacipran hydrochloride (ROR, 22.8; 95% CI, 8.46–61.4) for angle-closure glaucoma. CONCLUSION: A national pharmacovigilance database enabled us to identify the drugs that frequently induce glaucoma. The likelihood of the reporting of glaucoma varied among the drugs, which should be used carefully in clinical practice to avoid it. Dove 2023-11-29 /pmc/articles/PMC10693769/ /pubmed/38050555 http://dx.doi.org/10.2147/OPTH.S439255 Text en © 2023 Kozaru et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Kozaru, Mariko Iida, Tatsuya Hosohata, Keiko A Pharmacovigilance Study of Drug-Induced Glaucoma Utilizing the Japanese Adverse Event Reporting System |
title | A Pharmacovigilance Study of Drug-Induced Glaucoma Utilizing the Japanese Adverse Event Reporting System |
title_full | A Pharmacovigilance Study of Drug-Induced Glaucoma Utilizing the Japanese Adverse Event Reporting System |
title_fullStr | A Pharmacovigilance Study of Drug-Induced Glaucoma Utilizing the Japanese Adverse Event Reporting System |
title_full_unstemmed | A Pharmacovigilance Study of Drug-Induced Glaucoma Utilizing the Japanese Adverse Event Reporting System |
title_short | A Pharmacovigilance Study of Drug-Induced Glaucoma Utilizing the Japanese Adverse Event Reporting System |
title_sort | pharmacovigilance study of drug-induced glaucoma utilizing the japanese adverse event reporting system |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693769/ https://www.ncbi.nlm.nih.gov/pubmed/38050555 http://dx.doi.org/10.2147/OPTH.S439255 |
work_keys_str_mv | AT kozarumariko apharmacovigilancestudyofdruginducedglaucomautilizingthejapaneseadverseeventreportingsystem AT iidatatsuya apharmacovigilancestudyofdruginducedglaucomautilizingthejapaneseadverseeventreportingsystem AT hosohatakeiko apharmacovigilancestudyofdruginducedglaucomautilizingthejapaneseadverseeventreportingsystem AT kozarumariko pharmacovigilancestudyofdruginducedglaucomautilizingthejapaneseadverseeventreportingsystem AT iidatatsuya pharmacovigilancestudyofdruginducedglaucomautilizingthejapaneseadverseeventreportingsystem AT hosohatakeiko pharmacovigilancestudyofdruginducedglaucomautilizingthejapaneseadverseeventreportingsystem |